Immune reactivity to connective tissue antigens in pristane induced arthritis

Journal of Rheumatology

Volumn 31, Issue 8, 2004, Pages 1497-1505

  Morgan, Rebecca ^a   Wu, Bin ^a   Song, Zheng ^a   Wooley, Paul H ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUTZEL HOSPITAL   (United States)

Author keywords

Animal model; Autoimmunity; Pristane induced arthritis; Th1 response

Indexed keywords

AGGRECAN; ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; CYTOKINE; DERMATAN SULFATE; DNA; GAMMA INTERFERON; GLUCOSE 6 PHOSPHATE ISOMERASE; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; PRISTANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CELL PROLIFERATION; CONNECTIVE TISSUE; CYTOKINE PRODUCTION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; IMMUNOREACTIVITY; LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SERUM; SPLEEN; SUPERNATANT; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; AUTOANTIGENS; CELLS, CULTURED; CONNECTIVE TISSUE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED DBA; TERPENES;

EID: 3442887975     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Harris ED. Mechanisms of disease: rheumatoid arthritis - pathophysiology and implications for therapy. New Engl J Med 1990;322:1277-89.
2. Gioud Paquet M, Auvinet M, Raffin T, et al. IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 1987;46:65-71.
3. Singer JM, Plotz CM. The latex fixation test. 1. Application to the serological diagnosis of rheumatoid arthritis. Am J Med 1956;21:888-92.
4. Clague RB, Firth SA, Holt PJ, Skingle J, Greenbury CL, Webley M. Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann Rheum Dis 1983;42:537-44.
5. Wooley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens 1984;23:263-269.
6. Lettesjo H, Nordstrom E, Strom H, Moller E. Autoantibody patterns in synovial fluids from patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol 1998;48:293-9.
7. Austin AK, Hobbs RN, Anderson JC, Butler RC, Ashton BA. Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls. Ann Rheum Dis 1988;47:886-92.
8. Snowden N, Reynolds I, Morgan K, Holt L. T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. Arthritis Rheum 1997;40:1210-8.
9. Macht LM, Elson CJ, Kirwan JR, et al. Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60. Immunology 2000;99:208-14.
10. Stastny P. Association of the B cell alloantigen DRw4 with rheumatoid arthritis. New Engl J Med 1978;298:869-71.
11. Emery P, Gentry KC, Mackay IR, Muirden KD, Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987;30:849-56.
12. Sakane T, Takada S, Murakawa Y, Kotani H, Honda M, Ueda Y. Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells. J Immunol 1982;129:1972-7.
13. Janossy G, Panayi GS, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 1981;2:839-42.
14. de Kleer IM, Kamphuis SM, Rijkers GT, et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003;48:2001-10.
15. Klareskog L, Johnell O. Induced expression of class II transplantation antigens in the cartilage-pannus junction in RA: chronic synovitis as a model system for aberrant T-lymphocyte activation [review]. Br J Rheumatol 1988;27 Suppl 2:141-9.
16. Pitzalis C, Kingsley G, Haskard D, Panayi GS. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1990;18:1397-404.
17. Pitzalis C, Kingsley G, Murphy J, Panayi G. Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 1987;45:252-8.
18. Hovdenes J, Gaudernack G, Kvien TK, Egeland T, Mellbye OJ. A functional study of purified CD4+ and CD8+ cells isolated from synovial fluid of patients with rheumatoid arthritis and other arthritides. Scand J Immunol 1989;29:641-9.
19. Potter M, Wax JS. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol 1981;127:1591-5.
20. Wooley PH, Seibold JR, Whalen JD, Chapdelaine JM. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-30.
21. Chapdelaine JM, Whalen JD, Seibold JR, Wooley PH. Pristane-induced arthritis in mice: Genetic regulation and immunity in an experimental model of arthritis. In: David CS, editor. H-2 antigens. New York: Plenum; 1987:779-88.
22. Thompson SJ, Rook GA, Brealey RJ, Van der Zee R, Elson CJ. Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol 1990;20:2479-84.
23. Barker RN, Wells AD, Ghoraishian M, et al. Expression of mammalian 60-kD heat shock protein in the joints of mice with pristane-induced arthritis. Clin Exp Immunol 1996;103:83-8.
24. Barker RN, Easterfield AJ, Allen RF, Wells AD, Elson CJ, Thompson SJ. B- and T-cell autoantigens in pristane-induced arthritis. Immunology 1996;89:189-94.
25. Freund YR, Blair PB. Depression of natural killer activity and mitogen responsiveness in mice treated with pristane. J Immunol 1982;129:2826-31.
26. Garrett LR, Bost KL, Buttke TM, Cuchens MA. Changes in the DNA of lymphocytes from pristane treated rats. Agents Actions 1987;20:104-12.
27. Macht LM, Elson CJ, Kirwan JR, et al. Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60. Immunology 2000;99:208-14.
28. Stasiuk LM, Ghoraishian M, Elson CJ, Thompson SJ. Pristane-induced arthritis is CD4+ T-cell dependent. Immunology 1997;90:81-6.
29. Levitt NG, Fernandez-Madrid F, Wooley PH. Pristane induced arthritis in mice. IV. Immunotherapy with monoclonal antibodies directed against lymphocyte subsets. J Rheumatol 1992;19:1342-7.
30. Thompson SJ, Elson CJ. Susceptibility to pristane-induced arthritis is altered with changes in bowel flora. Immunol Lett 1993;36:227-31.
31. Wooley PH, Dutcher J, Widmer MB, Gillis S. Influence of a recombinant human soluble tumor necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice. J Immunol 1993;151:6602-7.
32. Myers LK, Tang B, Brand DD, Stuart JM, Kang AH. Characterization of an arthritogenic T cell determinant that induces collagen arthritis [abstract]. Arthritis Rheum 1998;41 Suppl:S215.
33. Cross AH, McCarron RM, McFarlin DE, Raine CS. Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observation on altered pathology by intercurrent virus infection. Lab Invest 1987;57:499-505.
34. Wooley PH, Whalen JD, Zimmerman JL, Champion TM. The effect of etodolac on type II collagen-induced arthritis in mice. Agents Actions 1987;21:244-6.
35. Olofsson P, Nordquist N, Vingsbo-Lundberg C, et al. Genetic links between the acute-phase response and arthritis development in rats. Arthritis Rheum 2002;46:259-68.
36. Francis JN, Lamont AG, Thompson SJ. The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis. Immunology 2000;99:338-44.
37. Lu S, Holmdahl R. Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats. Clin Immunol 1999;90:119-27.
38. Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999;286:1732-5.
39. Thompson SJ, Hitsumoto Y, Zhang YW, Rook GA, Elson CJ. Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin Exp Immunol 1992;89:434-8.
40. Dodge GR, Diaz A, Sanz-Rodriguez C, Reginato AM, Jimenez SA. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes. Arthritis Rheum 1998;41:274-83.
41. Elson CJ, Thompson SJ, Westacott CI, Bhoola KD. Mediators of joint swelling and damage in rheumatoid arthritis and pristane induced arthritis. Autoimmunity 1992;13:327-31.
42. Satoh M, Kuroda Y, Yoshida H, et al. Induction of lupus autoantibodies by adjuvants. J Autoimmun 2003;21:1-9.
43. Satoh M, Richards HB, Shaheen VM, et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 2000;121:399-405.
44. Corrigall VM, Bodman-Smith MD, Fife MS, et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol 2001;166:1492-8.
45. Blass S, Union A, Raymackers J, et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum 2001;44:761-71.
46. Thompson SJ, Thompson HS, Harper N, et al. Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology 1993;79:152-7.
47. Matsumoto I, Maccioni M, Lee DM, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002;3:360-5.
48. Thompson SJ, Hitsumoto Y, Ghoraishian M, Van der Zee R, Elson CJ. Cellular and humoral reactivity pattern to the mycobacterial heat shock protein hsp65 in pristane induced arthritis susceptible and hsp65 protected DBA/1 mice. Autoimmunity 1991;11:89-95.
49. Wooley PH, Whalen JD. Pristane-induced arthritis in mice. III. Lymphocyte phenotypic and functional abnormalities precede the development of pristane-induced arthritis. Cell Immunol 1991;138:251-9.